Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q1- Text added to 2022 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
New words:
addressed, agreed, barred, begun, Bhd, BridgeBio, chemoimmunotherapy, cisplatin, clawback, cognitive, dataset, deadline, discharge, disposition, doubled, driven, exhausted, factual, haematopoietic, hospital, inactive, ineligible, infection, lapse, LOTTE, lt, Malaysia, mortality, mRNA, multicenter, Nanocopoeia, NTRK, Oncogen, oncogenic, PAISLEY, permission, PILOT, plaque, platinum, POETYK, Point, post, precision, preserved, prohibit, PSO, Qilu, recommendation, recommended, recoverable, repotrectinib, responded, Responder, responding, satisfaction, Sdn, seroconversion, SLE, sponsored, statute, SUNBEAM, Syracuse, thalamic, tranche, Turning, VAT, waiting, withholding
Valuein 2022 Q1 filing- Value in 2022 Q2 filing
Original filings
Filing view